Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Vaccinex, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 27 | 22 | −5 |
| Shares | 4.64M | 4.61M | −29.4K (−0.6%) |
| Value | $5.03M | $2.28M | −$2.75M (−54.6%) |
New holders (0)
Institutions that held Vaccinex, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (5)
Institutions that held Vaccinex, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Two Sigma Securities, LLC | 54,651 | $59.0K |
| Goldman Sachs Group Inc | 22,472 | $24.0K |
| Captrust Financial Advisors | 5,000 | $5.00K |
| Financial Connections Group, Inc. | 4,044 | $4.00K |
| Ancora Advisors, LLC | 2,000 | $2.00K |